Skip to content

MedentiX

Active
Private limited companyfounded 20214 yrs activeHessenstraatje 1F, 2000 Antwerpen, BelgiumKBO/BCE: BE 0774.882.718

MedentiX has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €73k and a net result of €109k. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 11% of 16511 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Checked score

Score 2025
66 / 100
Healthy
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability81▼-19
Solvency32▼-23
Growth78=
Track record94
Bankruptcy probability, 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €4.5k at 30 days acceptable
Liquidity short (current ratio 0.96 against 1.0 in 2024; short-term debt: 15.3% and cash: 6.4% of total assets), and 93.3% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Seven signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 4 years 0 10 y
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
6.7%
Return on assets
10%
Age of the figures
9 mo
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 11% of 16511 sector peers (2025).
NBB · sector comparison
Position among 16511 sector peers
Solvency
better than 11%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 05-06-2026, 56 days ahead of the deadline.
NBB · 5 filings
Deviation from the deadline
2025
56 d early
2024
7 d early
2023
37 d early
2022
39 d early
2021
2 d late
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
20-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Equity
€73k▼ 49.2%
2024 · €143k
2021: €12k 2022: €123k 2023: €252k 2024: €143k
2021 → 2025
Total assets
€1.09M▲ 129%
2024 · €476k
2021: €59k 2022: €165k 2023: €309k 2024: €476k
2021 → 2025
Net result
€109k▼ 42.8%
2024 · €191k
2021: €7k 2022: €111k 2023: €129k 2024: €191k
2021 → 2025
Working capital
€-7k▼ 6,565%
2024 · €-100
2021: €9k 2022: €97k 2023: €227k 2024: €-100
2021 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Equity€12k-€123k▲ 937%€252k▲ 105%€143k▼ 43.1%€73k▼ 49.2%
Operating result€9k-€132k▲ 1,388%€160k▲ 22.0%€235k▲ 46.5%€156k▼ 33.5%
Net result€7k-€111k▲ 1,520%€129k▲ 16.5%€191k▲ 47.8%€109k▼ 42.8%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€100k€200kOperating result 2021: €9k€9kNet result 2021: €7k€7kOperating result 2022: €132k€132kNet result 2022: €111k€111kOperating result 2023: €160k€160kNet result 2023: €129k€129kOperating result 2024: €235k€235kNet result 2024: €191k€191kOperating result 2025: €156k€156kNet result 2025: €109k€109k20212022202320242025
The operating result falls in 2025; 2025 is 34% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.09M
Fixed assets €931k▲ 548%
Current assets €160k▼ 51.9%
Equity and liabilities €1.09M
Equity €73k▼ 49.2%
Debt €1.02M▲ 206%
The debt ratio rises from 69.8% to 93.3%. Equity is lower and debt is higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€258k
2024 · €241k
Cash flow
€211k
2024 · €197k
Solvency
6.7%
2024 · 30.2%
Current ratio
0.96
2024 · 1.00
Quick ratio
0.96
2024 · 1.00
Debt / equity
13.98
2024 · 2.32
ROE
150.2%
2024 · 133.3%
ROA
10.0%
2024 · 40.2%
Interest coverage
11.51
2024 · 3324.19
Debt
€1.02M
2024 · €332k
Debt ≤ 1 year
€167k
2024 · €332k
Debt > 1 year
€851k
Income taxes
€35k
2024 · €50k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet Code20242025
Assets
Total assets20/58€476k€1.09M
Fixed assets21/28€144k€931k
Tangible fixed assets22/27€144k€931k
Land and buildings22€117k€901k
Furniture and vehicles24€26k€30k
Current assets29/58€332k€160k
Amounts receivable within one year40/41€177k€68k
Trade receivables40€43k€42k
Other amounts receivable41€134k€26k
Current investments50/53-€11k
Cash at bank and in hand54/58€148k€69k
Deferred charges and accrued income490/1€8k€11k
Equity and liabilities
Total equity and liabilities10/49€476k€1.09M
Equity10/15€143k€73k
Contributions10/11€5k€5k=
Profit (loss) carried forward14€138k€68k
Amounts payable17/49€332k€1.02M
Amounts payable after more than one year17-€851k
Financial debts170/4-€851k
Amounts payable within one year42/48€332k€167k
Current portion of amounts payable after more than one year42-€35k
Financial debts43€683€478
Credit institutions430/8€683€478
Trade debts44€3k€10k
Suppliers440/4€3k€10k
Taxes, remuneration and social security45€28k€31k
Taxes450/3€28k€31k
Other amounts payable47/48€300k€90k
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€6k€101k
Other operating charges640/8€705€3k
Gross operating margin9900€242k€261k
Operating profit (loss)9901€235k€156k
Financial income75/76B€6k€11k
Recurring financial income75€6k€11k
Financial charges65/66B€73€22k
Recurring financial charges65€73€22k
Profit (loss) for the period before taxes9903€241k€144k
Income taxes67/77€50k€35k
Profit (loss) for the period9904€191k€109k
Profit (loss) for the period to be appropriated9905€191k€109k
Appropriation of the result
Profit (loss) to be appropriated9906€438k€248k
Profit (loss) brought forward from the previous period14P€247k€138k
Profit to be distributed694/7€300k€180k
Return on contributions (dividend)694€300k€180k

The notes to these accounts (6 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
05-06
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
2025
24-07
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial Highest result since 2021net €191k ▲47.8%
Operating result €235k, net result €191k, both a record.
24-06
NBB filing Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial Equity above €200kEq €252k ▲105%
3 profitable years in a row build equity to €252k.
22-06
NBB filing Annual accounts filed
fiscal year 2022 · micro schema
2022
31-12
Financial Liquidity triplescurrent ratio 3.29
Current ratio from 1.19 to 3.29; short-term debt falls from €47k to €42k.
31-12
Financial Equity above €100kEq €123k ▲937%
2 profitable years in a row build equity to €123k.
02-08
NBB filing Annual accounts filed
fiscal year 2021 · micro schema · 2 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Antwerpen · 1 establishment unit since 2021
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Hessenstraatje 1F2000 Antwerpen
Ground area
5,003 m²
Building footprint
325 m²
Volume, LiDAR
3,685 m³
Parcel 11802B0176/00X000, Flanders · tallest building 16.7 m, ±4 floors. Linked by address, not a title deed.
1 establishment unit
MedentiX
Hessenstraatje 1F, 2000 AntwerpenSpecialist medical practice
since 20212.322.806.441
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
11802B0176/00X000
ProtectedMonumentGodshuis Cornelis LantschotSource ↗
Flanders 5,003 m² 1 · 325 m² 16.7 m · 4 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
1 of these parcels carry protected heritage (source: regional heritage registers, Onroerend Erfgoed / patrimoine.brussels).

Similar companies · same sector, comparable size

Of 6,942 companies in sector 86230 we hold annual accounts for 4,291. 3,413 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded01-10-2021
Fiscal year end31-12
Activities, NACEBEL
86230Dental practice
86220Specialist medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 5 filingsAddress and cadastre registers

Data from official sources, last processed on 20-09-2026. Scores and ratios are computed by Checked and are not a credit decision.